REPLIGEN CORP — Director's Dealing 2021

Jan 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2021-01-25

Reporting Person: Snodgres Jon (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-25	Common Stock	M	4000	$33.87	Acquired	33498	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-25	Stock Option (Right to Buy)	$33.87	M	4000	Disposed	2028-03-01	Common Stock (4000)	Direct

Footnotes

F1: Shares vest and become exercisable as follows: 6,887 shares on 3/1/2021.